- Patent Title: Medicinal composition for promoting synthesis of protoporphyrin IX
-
Application No.: US14898581Application Date: 2014-06-13
-
Publication No.: US09603928B2Publication Date: 2017-03-28
- Inventor: Masahiro Ishizuka , Urara Oto , Atsuko Kamiya , Kiwamu Takahashi , Tohru Tanaka , Toshiyuki Ozawa , Kuniyuki Morimoto , Keitaro Watanabe
- Applicant: SBI Pharmaceuticals Co., Ltd. , Osaka City University
- Applicant Address: JP Tokyo JP Osaka
- Assignee: SBI Pharmaceuticals Co., Ltd.,Osaka City University
- Current Assignee: SBI Pharmaceuticals Co., Ltd.,Osaka City University
- Current Assignee Address: JP Tokyo JP Osaka
- Agency: Myers Bigel, P.A.
- Priority: JP2013-129057 20130619
- International Application: PCT/JP2014/065813 WO 20140613
- International Announcement: WO2014/203833 WO 20141224
- Main IPC: A61K31/195
- IPC: A61K31/195 ; A61K41/00 ; A61K45/06 ; A61K31/197 ; A61K31/198 ; A61K31/375 ; A61K33/40 ; A61K31/16 ; A61K31/194
Abstract:
The object of the present invention is to elucidate the resistance mechanism in infections that show resistance to ALA-PDT that uses a single ALA, and to provide a novel treatment method against these infections. The present invention provides a pharmaceutical composition for promoting protoporphyrin IX production in ALA-PDT for treating infection, characterized in that it comprises a substance that promotes the conversion from coproporphyrinogen III to protoporphyrin IX.
Public/Granted literature
- US20160136274A1 MEDICINAL COMPOSITION FOR PROMOTING SYNTHESIS OF PROTOPORPHYRIN IX Public/Granted day:2016-05-19
Information query
